Remission of lupus nephritis: the trajectory of histological response in successfully treated patients

• Published in: Lupus science & medicine Vol. 10; no. 1; p. e000932
• Main Authors: Malvar, Ana, Alberton, Valeria, Lococo, Bruno, Lourenco, Maria, Martinez, Joaquin, Burna, Lucrecia, Besso, Celeste, Navarro, Jordi, Nagaraja, Haikady N, Khatiwada, Aastha, Wolf, Bethany, Rovin, Brad
• Format: Journal Article
• Language: English
• Published: England Lupus Foundation of America 01.05.2023; BMJ Publishing Group LTD; BMJ Publishing Group
• Series: Original research
• Subjects: autoimmune diseases; Biopsy; Humans; Immunology; Inflammation; Kidney - pathology; Kidney Glomerulus - pathology; Kidneys; Leukocytes; Lupus; Lupus Erythematosus, Systemic - pathology; Lupus Nephritis; Lupus Nephritis - complications; Lupus Nephritis - drug therapy; Lupus Nephritis - pathology; Microscopy; Necrosis; Nephrology; Patients; Remission (Medicine); Renal Insufficiency, Chronic; Rheumatology; autoimmune diseases; inflammation; lupus nephritis
• ISSN: 2053-8790; 2053-8790
• DOI: 10.1136/lupus-2023-000932

ObjectiveThis study investigated changes in kidney histology over time in patients with lupus nephritis (LN) undergoing immunosuppressive treatment.MethodsPatients with proliferative±membranous LN were studied. After a diagnostic kidney biopsy (Bx1), patients had protocol biopsy 2 (Bx2) at 9 (6–15) months and protocol biopsy 3 (Bx3) at 42 (28–67) months. Kidney histological activity and chronicity indices (AI, CI) were measured.ResultsAI declined in a biphasic fashion, falling rapidly between Bx1 and Bx2 and then more slowly between Bx2 and Bx3. Patients were divided into those who achieved histological remission, defined as an AI=0 at Bx3 (group 1), and those with persistent histological activity (AI >0) at Bx3 (group 2). The early decline in AI was 1.6 times greater (95% CI 1.30, 1.91) in group 1 than group 2 (p=0.01). Between Bx2 and Bx3, the AI decline was 2.19-fold greater (95% CI 2.09, 2.29) in group 1 versus group 2 (p=7.34×10−5). Individual histological components of the AI resolved at different rates. Inflammatory lesions like glomerular crescents, karyorrhexis and necrosis mostly resolved by Bx2, whereas endocapillary hypercellularity, subendothelial hyaline deposits and interstitial inflammation resolved slowly, accounting for residual histological activity at biopsy 3 in group 2. In contrast, CI increased rapidly, by 0.15 units/month between Bx1 and Bx2, then plateaued. There were no differences in the rate of accumulation of chronic damage between group 1 and group 2. The increase in CI was significantly related to the severity of glomerular crescents (p=0.044), subendothelial hyaline deposits (p=0.002) and interstitial inflammation (p=0.015) at Bx1.ConclusionsLN histological activity takes months to years to resolve, providing a rationale for the need of long-term, well-tolerated maintenance immunosuppression. Despite responding, LN kidneys accrue chronic damage early during treatment. This finding provides an explanation for the association of chronic progressive kidney disease with recurrent episodes of LN.